Methods and Compositions for Modulating Lung Cancer Tumor Initiating Cells (TIC), and Oxytocin Receptor (OXTR) Modulatory Agents for Use in Practicing the Same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Jul 6, 2015
filing date -
Jul 7, 2014
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Methods of modulating lung cancer, e.g., squamous cell carcinoma (SQCC), tumor initiating cells (TIC) are provided. Aspects of the methods including contacting a TIC with an OXTR modulatory agent, e.g., an inhibitory agent, in a manner sufficient to modulate the TIC. Aspects of the invention further include compositions that find use in practicing methods of the method. The methods and compositions find use in a variety of different applications, including but not limited to the treatment of SQCC.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully